AzTrials
AzTrials

LaparoscopyPhase 2/3NCT00828035

Light Endoscopic Robot Use in Laparoscopic Surgery

A Phase 2/3 study testing laparoscopic surgery in people with Laparoscopy, run by University Hospital, Grenoble at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Light Endoscopic Robot evaluation in abdominal and urological laparoscopic surgery : surgery with surgeon and robot (REL group = new treatment) versus surgery with surgeon and assistant (AO group - standard treatment) Primary outcome measure : Number of useful hands (light endoscopic robot = one useful mechanical hand) Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Laparoscopy
What is being tested?
laparoscopic surgery
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
2 sitesFrance
Study dates
Apr 2008to Apr 2011
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Laparoscopic surgery indicated
  • Subject with ASA Score 1, 2 or 3
  • Subject with health and social protection
  • 18 years of age or older
  • Written Informed Consent

Who cannot join

  • Subject is pregnant or lactating
  • Subject in jail
  • Subject hospitalizes without consent
  • Protected persons aged 18 years or older
  • Subject participated in another study

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • University Hospital, Grenoble

    Grenoble, Isère

  • University Hospital, Saint-Etienne

    Saint-Étienne-de-Montluc, Pays de la Loire Region

Other trials in France

About this study

Official title: Light Endoscopic Robot Use in Abdominal and Urological Laparoscopic Surgery

Light Endoscopic Robot evaluation in abdominal and urological laparoscopic surgery : surgery with surgeon and robot (REL group = new treatment) versus surgery with surgeon and assistant (AO group - standard treatment)

Primary outcome measure : Number of useful hands (light endoscopic robot = one useful mechanical hand)

Conditions
Laparoscopy
Being tested
laparoscopic surgery
Keywords
robotics, laparoscopy, surgery, computer assisted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • laparoscopic surgeryProcedure or surgery

    Also called robotic laparoscopic surgery, robotic abdominal laparoscopic surgery, robotic urological laparoscopic surgery

    comparison of two different laparoscopic surgeries : robot versus human

Study groups in NCT00828035
Study groupRoleWhat they receive
1, RELOtherrel group : patients with light endoscopic robot
Receives: Procedure: laparoscopic surgery
2, AOActive comparatorAO group : Patients with surgery assistant
Receives: Procedure: laparoscopic surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of useful hands, robot as a useful mechanical hand

    Measured: one month

Secondary outcomes (6)
  1. To evaluate reliability and limits of light endoscopic robot : Number of breakdown, failure (manipulation, voice recognition, other )

    Measured: one month

  2. Compare surgeon's visual comfort in two groups (REL group and AO group) : evaluate scale of surgeon's visual comfort during surgery

    Measured: one month

  3. Compare surgery's periods

    Measured: one month

  4. Evaluate complications : Number of complications (per operative, post operative)

    Measured: one month

  5. Evaluate medical and paramedical use of light endoscopic robot : apprentice time, labour time

    Measured: one month

  6. Medical and economic evaluation : cost benefit analysis : human cost, cost

    Measured: one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2009 (estimated)
  2. Study startApr 2008
  3. Primary completionApr 2008
  4. Study completionApr 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
78 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00828035
Sponsor's protocol ID
DCIC 03 39
Other IDs
ENDOCONTROL company
Status last verified
Sep 2012
First submitted
22 Jan 2009
Last updated
18 Sep 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Long JA, Descotes JL, Skowron O, Troccaz J, Cinquin P, Boillot B, Terrier N, Rambeaud JJ. [Use of robotics in laparoscopic urological surgery: state of the art]. Prog Urol. 2006 Feb;16(1):3-11. French.

    PubMed 16526532
  • Aiono S, Gilbert JM, Soin B, Finlay PA, Gordan A. Controlled trial of the introduction of a robotic camera assistant (EndoAssist) for laparoscopic cholecystectomy. Surg Endosc. 2002 Sep;16(9):1267-70. doi: 10.1007/s00464-001-9174-7. Epub 2002 Jun 14.

    PubMed 12235507
  • Jarry J, Moreau Gaudry A, Long JA, Chipon E, Cinquin P, Faucheron JL. Miniaturized robotic laparoscope-holder for rectopexy: first results of a prospective study. J Laparoendosc Adv Surg Tech A. 2013 Apr;23(4):351-5. doi: 10.1089/lap.2012.0233. Epub 2013 Mar 11.

    PubMed 23477369

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing laparoscopic surgery in people with Laparoscopy, run by University Hospital, Grenoble at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Sep 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of useful hands, robot as a useful mechanical hand (time frame: one month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00828035, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in